Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SFBC working group "Biochemical markers of COVID-19".

Identifieur interne : 000658 ( Main/Exploration ); précédent : 000657; suivant : 000659

SFBC working group "Biochemical markers of COVID-19".

Auteurs : Marie-Christine Beauvieux [France] ; Annie M. Bérard [France] ; Isabelle Aimone-Gastin [France] ; Françoise Barbé [France] ; Yann Barguil [France] ; Delphine Collin-Chavagnac [France] ; Hervé Delacour [France] ; Céline Delevallée [France] ; Valérie Nivet-Antoine [France] ; Katell Peoc'H [France] ; Carole Poupon [France] ; François Schmitt [France] ; Laurence Piéroni [France] ; Vincent Sapin [France]

Source :

RBID : pubmed:32540814

Descripteurs français

English descriptors

Abstract

The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.

DOI: 10.1684/abc.2020.1563
PubMed: 32540814


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SFBC working group "Biochemical markers of COVID-19".</title>
<author>
<name sortKey="Beauvieux, Marie Christine" sort="Beauvieux, Marie Christine" uniqKey="Beauvieux M" first="Marie-Christine" last="Beauvieux">Marie-Christine Beauvieux</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux</wicri:regionArea>
<wicri:noRegion>UMR5536 CNRS Université Bordeaux</wicri:noRegion>
<wicri:noRegion>UMR5536 CNRS Université Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berard, Annie M" sort="Berard, Annie M" uniqKey="Berard A" first="Annie M" last="Bérard">Annie M. Bérard</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie, CHU de Bordeaux ; Université Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie, CHU de Bordeaux ; Université Bordeaux</wicri:regionArea>
<wicri:noRegion>CHU de Bordeaux ; Université Bordeaux</wicri:noRegion>
<wicri:noRegion>CHU de Bordeaux ; Université Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Aimone Gastin, Isabelle" sort="Aimone Gastin, Isabelle" uniqKey="Aimone Gastin I" first="Isabelle" last="Aimone-Gastin">Isabelle Aimone-Gastin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Vandœuvre-lès-Nancy</settlement>
<settlement type="city" wicri:auto="agglo">Nancy</settlement>
</placeName>
<orgName type="university">Université de Lorraine</orgName>
</affiliation>
</author>
<author>
<name sortKey="Barbe, Francoise" sort="Barbe, Francoise" uniqKey="Barbe F" first="Françoise" last="Barbé">Françoise Barbé</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy</wicri:regionArea>
<wicri:noRegion>CHU de Nancy</wicri:noRegion>
<wicri:noRegion>CHU de Nancy</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barguil, Yann" sort="Barguil, Yann" uniqKey="Barguil Y" first="Yann" last="Barguil">Yann Barguil</name>
<affiliation wicri:level="1">
<nlm:affiliation>UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie</wicri:regionArea>
<wicri:noRegion>Nouvelle-Calédonie</wicri:noRegion>
<wicri:noRegion>Nouvelle-Calédonie</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Collin Chavagnac, Delphine" sort="Collin Chavagnac, Delphine" uniqKey="Collin Chavagnac D" first="Delphine" last="Collin-Chavagnac">Delphine Collin-Chavagnac</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon</wicri:regionArea>
<wicri:noRegion>Hospices civils de Lyon</wicri:noRegion>
<wicri:noRegion>Hospices civils de Lyon</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Delacour, Herve" sort="Delacour, Herve" uniqKey="Delacour H" first="Hervé" last="Delacour">Hervé Delacour</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé</wicri:regionArea>
<wicri:noRegion>Saint-Mandé</wicri:noRegion>
<wicri:noRegion>Saint-Mandé</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Delevallee, Celine" sort="Delevallee, Celine" uniqKey="Delevallee C" first="Céline" last="Delevallée">Céline Delevallée</name>
<affiliation wicri:level="3">
<nlm:affiliation>LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nivet Antoine, Valerie" sort="Nivet Antoine, Valerie" uniqKey="Nivet Antoine V" first="Valérie" last="Nivet-Antoine">Valérie Nivet-Antoine</name>
<affiliation wicri:level="1">
<nlm:affiliation>DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris</wicri:regionArea>
<wicri:noRegion>Faculté de pharmacie et Université de Paris</wicri:noRegion>
<wicri:noRegion>Faculté de pharmacie et Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peoc H, Katell" sort="Peoc H, Katell" uniqKey="Peoc H K" first="Katell" last="Peoc'H">Katell Peoc'H</name>
<affiliation wicri:level="1">
<nlm:affiliation>HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris</wicri:regionArea>
<wicri:noRegion>Laboratoires de biochimie ; Université de Paris</wicri:noRegion>
<wicri:noRegion>Laboratoires de biochimie ; Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Poupon, Carole" sort="Poupon, Carole" uniqKey="Poupon C" first="Carole" last="Poupon">Carole Poupon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratoire de biologie médicale, Centre hospitalier de Gonesse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biologie médicale, Centre hospitalier de Gonesse</wicri:regionArea>
<wicri:noRegion>Centre hospitalier de Gonesse</wicri:noRegion>
<wicri:noRegion>Centre hospitalier de Gonesse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schmitt, Francois" sort="Schmitt, Francois" uniqKey="Schmitt F" first="François" last="Schmitt">François Schmitt</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient</wicri:regionArea>
<placeName>
<region type="region">Région Bretagne</region>
<region type="old region">Région Bretagne</region>
<settlement type="city">Lorient</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pieroni, Laurence" sort="Pieroni, Laurence" uniqKey="Pieroni L" first="Laurence" last="Piéroni">Laurence Piéroni</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie</wicri:regionArea>
<wicri:noRegion>Département de biochimie</wicri:noRegion>
<wicri:noRegion>Département de biochimie</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sapin, Vincent" sort="Sapin, Vincent" uniqKey="Sapin V" first="Vincent" last="Sapin">Vincent Sapin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne</wicri:regionArea>
<wicri:noRegion>Université Clermont Auvergne</wicri:noRegion>
<wicri:noRegion>Université Clermont Auvergne</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32540814</idno>
<idno type="pmid">32540814</idno>
<idno type="doi">10.1684/abc.2020.1563</idno>
<idno type="wicri:Area/Main/Corpus">000D79</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000D79</idno>
<idno type="wicri:Area/Main/Curation">000D79</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000D79</idno>
<idno type="wicri:Area/Main/Exploration">000D79</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">SFBC working group "Biochemical markers of COVID-19".</title>
<author>
<name sortKey="Beauvieux, Marie Christine" sort="Beauvieux, Marie Christine" uniqKey="Beauvieux M" first="Marie-Christine" last="Beauvieux">Marie-Christine Beauvieux</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux</wicri:regionArea>
<wicri:noRegion>UMR5536 CNRS Université Bordeaux</wicri:noRegion>
<wicri:noRegion>UMR5536 CNRS Université Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berard, Annie M" sort="Berard, Annie M" uniqKey="Berard A" first="Annie M" last="Bérard">Annie M. Bérard</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie, CHU de Bordeaux ; Université Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie, CHU de Bordeaux ; Université Bordeaux</wicri:regionArea>
<wicri:noRegion>CHU de Bordeaux ; Université Bordeaux</wicri:noRegion>
<wicri:noRegion>CHU de Bordeaux ; Université Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Aimone Gastin, Isabelle" sort="Aimone Gastin, Isabelle" uniqKey="Aimone Gastin I" first="Isabelle" last="Aimone-Gastin">Isabelle Aimone-Gastin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Vandœuvre-lès-Nancy</settlement>
<settlement type="city" wicri:auto="agglo">Nancy</settlement>
</placeName>
<orgName type="university">Université de Lorraine</orgName>
</affiliation>
</author>
<author>
<name sortKey="Barbe, Francoise" sort="Barbe, Francoise" uniqKey="Barbe F" first="Françoise" last="Barbé">Françoise Barbé</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy</wicri:regionArea>
<wicri:noRegion>CHU de Nancy</wicri:noRegion>
<wicri:noRegion>CHU de Nancy</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barguil, Yann" sort="Barguil, Yann" uniqKey="Barguil Y" first="Yann" last="Barguil">Yann Barguil</name>
<affiliation wicri:level="1">
<nlm:affiliation>UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie</wicri:regionArea>
<wicri:noRegion>Nouvelle-Calédonie</wicri:noRegion>
<wicri:noRegion>Nouvelle-Calédonie</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Collin Chavagnac, Delphine" sort="Collin Chavagnac, Delphine" uniqKey="Collin Chavagnac D" first="Delphine" last="Collin-Chavagnac">Delphine Collin-Chavagnac</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon</wicri:regionArea>
<wicri:noRegion>Hospices civils de Lyon</wicri:noRegion>
<wicri:noRegion>Hospices civils de Lyon</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Delacour, Herve" sort="Delacour, Herve" uniqKey="Delacour H" first="Hervé" last="Delacour">Hervé Delacour</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé</wicri:regionArea>
<wicri:noRegion>Saint-Mandé</wicri:noRegion>
<wicri:noRegion>Saint-Mandé</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Delevallee, Celine" sort="Delevallee, Celine" uniqKey="Delevallee C" first="Céline" last="Delevallée">Céline Delevallée</name>
<affiliation wicri:level="3">
<nlm:affiliation>LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nivet Antoine, Valerie" sort="Nivet Antoine, Valerie" uniqKey="Nivet Antoine V" first="Valérie" last="Nivet-Antoine">Valérie Nivet-Antoine</name>
<affiliation wicri:level="1">
<nlm:affiliation>DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris</wicri:regionArea>
<wicri:noRegion>Faculté de pharmacie et Université de Paris</wicri:noRegion>
<wicri:noRegion>Faculté de pharmacie et Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peoc H, Katell" sort="Peoc H, Katell" uniqKey="Peoc H K" first="Katell" last="Peoc'H">Katell Peoc'H</name>
<affiliation wicri:level="1">
<nlm:affiliation>HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris</wicri:regionArea>
<wicri:noRegion>Laboratoires de biochimie ; Université de Paris</wicri:noRegion>
<wicri:noRegion>Laboratoires de biochimie ; Université de Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Poupon, Carole" sort="Poupon, Carole" uniqKey="Poupon C" first="Carole" last="Poupon">Carole Poupon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratoire de biologie médicale, Centre hospitalier de Gonesse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biologie médicale, Centre hospitalier de Gonesse</wicri:regionArea>
<wicri:noRegion>Centre hospitalier de Gonesse</wicri:noRegion>
<wicri:noRegion>Centre hospitalier de Gonesse</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schmitt, Francois" sort="Schmitt, Francois" uniqKey="Schmitt F" first="François" last="Schmitt">François Schmitt</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient</wicri:regionArea>
<placeName>
<region type="region">Région Bretagne</region>
<region type="old region">Région Bretagne</region>
<settlement type="city">Lorient</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pieroni, Laurence" sort="Pieroni, Laurence" uniqKey="Pieroni L" first="Laurence" last="Piéroni">Laurence Piéroni</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie</wicri:regionArea>
<wicri:noRegion>Département de biochimie</wicri:noRegion>
<wicri:noRegion>Département de biochimie</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sapin, Vincent" sort="Sapin, Vincent" uniqKey="Sapin V" first="Vincent" last="Sapin">Vincent Sapin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne</wicri:regionArea>
<wicri:noRegion>Université Clermont Auvergne</wicri:noRegion>
<wicri:noRegion>Université Clermont Auvergne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Annales de biologie clinique</title>
<idno type="eISSN">1950-6112</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (isolation & purification)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>Biochemistry (organization & administration)</term>
<term>Biochemistry (standards)</term>
<term>Biomarkers (analysis)</term>
<term>Biomarkers (blood)</term>
<term>Clinical Laboratory Services (organization & administration)</term>
<term>Clinical Laboratory Services (standards)</term>
<term>Community Networks (organization & administration)</term>
<term>Community Networks (standards)</term>
<term>Community Networks (trends)</term>
<term>Coronavirus Infections (blood)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Disease Outbreaks (MeSH)</term>
<term>France (epidemiology)</term>
<term>History, 21st Century (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Intersectoral Collaboration (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (blood)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Professional Practice (organization & administration)</term>
<term>Professional Practice (standards)</term>
<term>Professional Practice (trends)</term>
<term>Societies, Scientific (organization & administration)</term>
<term>Societies, Scientific (standards)</term>
<term>Videoconferencing (organization & administration)</term>
<term>Videoconferencing (standards)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (isolement et purification)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Biochimie (normes)</term>
<term>Biochimie (organisation et administration)</term>
<term>Collaboration intersectorielle (MeSH)</term>
<term>Communication par vidéoconférence (normes)</term>
<term>Communication par vidéoconférence (organisation et administration)</term>
<term>France (épidémiologie)</term>
<term>Histoire du 21ème siècle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (sang)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Marqueurs biologiques (analyse)</term>
<term>Marqueurs biologiques (sang)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (sang)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Pratique professionnelle (normes)</term>
<term>Pratique professionnelle (organisation et administration)</term>
<term>Pratique professionnelle (tendances)</term>
<term>Réseaux communautaires (normes)</term>
<term>Réseaux communautaires (organisation et administration)</term>
<term>Réseaux communautaires (tendances)</term>
<term>Services de laboratoire d'analyses médicales (normes)</term>
<term>Services de laboratoire d'analyses médicales (organisation et administration)</term>
<term>Sociétés savantes (normes)</term>
<term>Sociétés savantes (organisation et administration)</term>
<term>Épidémies de maladies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Marqueurs biologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr">
<term>Biochimie</term>
<term>Communication par vidéoconférence</term>
<term>Pratique professionnelle</term>
<term>Réseaux communautaires</term>
<term>Services de laboratoire d'analyses médicales</term>
<term>Sociétés savantes</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Biochimie</term>
<term>Communication par vidéoconférence</term>
<term>Pratique professionnelle</term>
<term>Réseaux communautaires</term>
<term>Services de laboratoire d'analyses médicales</term>
<term>Sociétés savantes</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Biochemistry</term>
<term>Clinical Laboratory Services</term>
<term>Community Networks</term>
<term>Professional Practice</term>
<term>Societies, Scientific</term>
<term>Videoconferencing</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Marqueurs biologiques</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en">
<term>Biochemistry</term>
<term>Clinical Laboratory Services</term>
<term>Community Networks</term>
<term>Professional Practice</term>
<term>Societies, Scientific</term>
<term>Videoconferencing</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr">
<term>Pratique professionnelle</term>
<term>Réseaux communautaires</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Community Networks</term>
<term>Professional Practice</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>France</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Outbreaks</term>
<term>History, 21st Century</term>
<term>Humans</term>
<term>Intersectoral Collaboration</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Collaboration intersectorielle</term>
<term>Histoire du 21ème siècle</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Épidémies de maladies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14
<sup>th</sup>
, the start of the planned containment exit from May 11
<sup>th</sup>
. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32540814</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>06</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1950-6112</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>78</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Annales de biologie clinique</Title>
<ISOAbbreviation>Ann. Biol. Clin. (Paris)</ISOAbbreviation>
</Journal>
<ArticleTitle>SFBC working group "Biochemical markers of COVID-19".</ArticleTitle>
<Pagination>
<MedlinePgn>269-277</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/abc.2020.1563</ELocationID>
<Abstract>
<AbstractText>The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14
<sup>th</sup>
, the start of the planned containment exit from May 11
<sup>th</sup>
. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Beauvieux</LastName>
<ForeName>Marie-Christine</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bérard</LastName>
<ForeName>Annie M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Service de biochimie, CHU de Bordeaux ; Université Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aimone-Gastin</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbé</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barguil</LastName>
<ForeName>Yann</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Collin-Chavagnac</LastName>
<ForeName>Delphine</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delacour</LastName>
<ForeName>Hervé</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delevallée</LastName>
<ForeName>Céline</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nivet-Antoine</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peoc'h</LastName>
<ForeName>Katell</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poupon</LastName>
<ForeName>Carole</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de biologie médicale, Centre hospitalier de Gonesse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmitt</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piéroni</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sapin</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Membres du Groupe de travail SFBC « Marqueurs biochimiques de COVID-19 »</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe Privés</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe Outre-Mer (OM)/francophonie</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CH</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe Hôpitaux d’instruction des armées (HIA)</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CHU Nord-Est</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CHU Ouest</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CHU Assistance publique-Hôpitaux de Paris (AP-HP)</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CHU Sud</CollectiveName>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sous-groupe CHU Auvergne Rhône-Alpes-Bourgogne Franche-Comté (ARA-BFC)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016456">Historical Article</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Groupe de travail SFBC « Marqueurs biochimiques de COVID-19 ».</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Ann Biol Clin (Paris)</MedlineTA>
<NlmUniqueID>2984690R</NlmUniqueID>
<ISSNLinking>0003-3898</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001671" MajorTopicYN="N">Biochemistry</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064790" MajorTopicYN="N">Clinical Laboratory Services</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019058" MajorTopicYN="N">Community Networks</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000070516" MajorTopicYN="N">Intersectoral Collaboration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011364" MajorTopicYN="N">Professional Practice</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012958" MajorTopicYN="N">Societies, Scientific</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049269" MajorTopicYN="N">Videoconferencing</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">biological markers</Keyword>
<Keyword MajorTopicYN="N">medical biology</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Aimone-Gastin</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alcaraz</LastName>
<ForeName>Stéphanie</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Allouche</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balduyck</LastName>
<ForeName>Malika</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barbé</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barguil</LastName>
<ForeName>Yann</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bastard</LastName>
<ForeName>Jean-Philippe</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beaudeux</LastName>
<ForeName>Jean-Louis</ForeName>
<Initials>JL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beauvieux</LastName>
<ForeName>Marie-Christine</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ben Lassoued</LastName>
<ForeName>Amin</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benz de Bretagne</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bérard</LastName>
<ForeName>Annie</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bermont</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bigot-Corbel</LastName>
<ForeName>Edith</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bost</LastName>
<ForeName>Muriel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bourbonneux</LastName>
<ForeName>Valery</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brunel</LastName>
<ForeName>Valery</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carré</LastName>
<ForeName>Jean-Luc</ForeName>
<Initials>JL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chenevier-Gobeaux</LastName>
<ForeName>Camille</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chevrier</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chinetti</LastName>
<ForeName>Giulia</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Collin-Chavagnac</LastName>
<ForeName>Delphine</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Delacour</LastName>
<ForeName>Hervé</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Delevallée</LastName>
<ForeName>Delphine</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Desroys du Roure</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Faure</LastName>
<ForeName>Patrice</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Galhaud</LastName>
<ForeName>Jean-Philippe</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Galinier</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hauet</LastName>
<ForeName>Thierry</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hejl</LastName>
<ForeName>Carine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jolly</LastName>
<ForeName>Emilie</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kamel</LastName>
<ForeName>Said</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lehmann</LastName>
<ForeName>Sylvain</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leroy</LastName>
<ForeName>Aline</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lessinger</LastName>
<ForeName>Jean-Marc</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pacifique</LastName>
<ForeName>Levy</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lorec-Penet</LastName>
<ForeName>Anne-Marie</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mesli</LastName>
<ForeName>Samir</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Monnet</LastName>
<ForeName>Dagui</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moreau</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mouly</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nivet-Antoine</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oueidat</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pecquet</LastName>
<ForeName>Mathieu</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peoc'h</LastName>
<ForeName>Katell</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Piéroni</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Poupon</LastName>
<ForeName>Carole</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Roubille</LastName>
<ForeName>Martine</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rucheton</LastName>
<ForeName>Benoit</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sakka</LastName>
<ForeName>Medhi</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sapin</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saunier</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scherrer</LastName>
<ForeName>Florian</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schmitt</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zaepfel</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zozor</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulier</LastName>
<ForeName>Alexandre</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saint Martin</LastName>
<ForeName>Chloé</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chatelain</LastName>
<ForeName>Chatelain</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chatelain</LastName>
<ForeName>Guillaume</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Froment</LastName>
<ForeName>Pauline</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paulus</LastName>
<ForeName>Jean-Marcel</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Merah</LastName>
<ForeName>Kader</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sevin</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barrand</LastName>
<ForeName>Lionel</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boetsch</LastName>
<ForeName>Morgane</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lautier</LastName>
<ForeName>Carine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Charrier</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Magraff</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cavalier</LastName>
<ForeName>Etienne</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Demar</LastName>
<ForeName>Magali</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Guire</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wang Han</LastName>
<ForeName>Ting</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laso Bautista</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dumas-Chastang</LastName>
<ForeName>Elsa</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Outreville</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tayeb</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Monde</LastName>
<ForeName>Absalome</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chiaradia</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alomar</LastName>
<ForeName>Yves</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Devaud</LastName>
<ForeName>Francois</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diallo</LastName>
<ForeName>Fatou Agne</ForeName>
<Initials>FA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kandji</LastName>
<ForeName>Pape Matar</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gueye</LastName>
<ForeName>Papa Madieye</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Temmar</LastName>
<ForeName>Abdelhakim</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sakandé</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kabré</LastName>
<ForeName>Elie</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Padelli</LastName>
<ForeName>Maëël</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chabraoui</LastName>
<ForeName>Layachi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Magny</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Got</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Francia</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tournoys</LastName>
<ForeName>Marie-Hélène</ForeName>
<Initials>MH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morvan</LastName>
<ForeName>Cécile</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kadi</LastName>
<ForeName>Habiba</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balluet</LastName>
<ForeName>Rémi</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fissor-Magdelein</LastName>
<ForeName>Cristel</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vest</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Plantamura</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salignac</LastName>
<ForeName>Sylvain</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maboudou</LastName>
<ForeName>Patrice</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Onraed</LastName>
<ForeName>Brigitte</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Szymezak</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alemann</LastName>
<ForeName>Mathieu</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Glady</LastName>
<ForeName>Ludovic</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lavaux</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kemmel</LastName>
<ForeName>Véronique</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lefevre</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bayer</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Billoir</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gueudin</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grandhomme</LastName>
<ForeName>Frédérique</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gondolf</LastName>
<ForeName>Clémentine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moal</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Larcher-Joubaud</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guery</LastName>
<ForeName>Eve-Anne</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lefevre</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Collet</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peltier</LastName>
<ForeName>Lucas</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lacape</LastName>
<ForeName>Geneviève</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Redonnet-Vernhet</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Richard</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gilleron</LastName>
<ForeName>Véronique</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Czerkiewicz</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vicca</LastName>
<ForeName>Stéphanie</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Manceau</LastName>
<ForeName>Hanna</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boutten</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ausseil</LastName>
<ForeName>Jérôme</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hamoir</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zemori</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deconde-Lebutor</LastName>
<ForeName>Célia</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lamy</LastName>
<ForeName>Anaïs</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gambert</LastName>
<ForeName>Ségolène</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gonzalo</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cartier</LastName>
<ForeName>Régine</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oris</LastName>
<ForeName>Charlotte</ForeName>
<Initials>C</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32540814</ArticleId>
<ArticleId IdType="pii">abc.2020.1563</ArticleId>
<ArticleId IdType="doi">10.1684/abc.2020.1563</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Auvergne (région administrative)</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Grand Est</li>
<li>Lorraine (région)</li>
<li>Région Bretagne</li>
</region>
<settlement>
<li>Clermont-Ferrand</li>
<li>Lorient</li>
<li>Nancy</li>
<li>Vandœuvre-lès-Nancy</li>
</settlement>
<orgName>
<li>Université de Lorraine</li>
</orgName>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Beauvieux, Marie Christine" sort="Beauvieux, Marie Christine" uniqKey="Beauvieux M" first="Marie-Christine" last="Beauvieux">Marie-Christine Beauvieux</name>
</noRegion>
<name sortKey="Aimone Gastin, Isabelle" sort="Aimone Gastin, Isabelle" uniqKey="Aimone Gastin I" first="Isabelle" last="Aimone-Gastin">Isabelle Aimone-Gastin</name>
<name sortKey="Barbe, Francoise" sort="Barbe, Francoise" uniqKey="Barbe F" first="Françoise" last="Barbé">Françoise Barbé</name>
<name sortKey="Barguil, Yann" sort="Barguil, Yann" uniqKey="Barguil Y" first="Yann" last="Barguil">Yann Barguil</name>
<name sortKey="Berard, Annie M" sort="Berard, Annie M" uniqKey="Berard A" first="Annie M" last="Bérard">Annie M. Bérard</name>
<name sortKey="Collin Chavagnac, Delphine" sort="Collin Chavagnac, Delphine" uniqKey="Collin Chavagnac D" first="Delphine" last="Collin-Chavagnac">Delphine Collin-Chavagnac</name>
<name sortKey="Delacour, Herve" sort="Delacour, Herve" uniqKey="Delacour H" first="Hervé" last="Delacour">Hervé Delacour</name>
<name sortKey="Delevallee, Celine" sort="Delevallee, Celine" uniqKey="Delevallee C" first="Céline" last="Delevallée">Céline Delevallée</name>
<name sortKey="Nivet Antoine, Valerie" sort="Nivet Antoine, Valerie" uniqKey="Nivet Antoine V" first="Valérie" last="Nivet-Antoine">Valérie Nivet-Antoine</name>
<name sortKey="Peoc H, Katell" sort="Peoc H, Katell" uniqKey="Peoc H K" first="Katell" last="Peoc'H">Katell Peoc'H</name>
<name sortKey="Pieroni, Laurence" sort="Pieroni, Laurence" uniqKey="Pieroni L" first="Laurence" last="Piéroni">Laurence Piéroni</name>
<name sortKey="Poupon, Carole" sort="Poupon, Carole" uniqKey="Poupon C" first="Carole" last="Poupon">Carole Poupon</name>
<name sortKey="Sapin, Vincent" sort="Sapin, Vincent" uniqKey="Sapin V" first="Vincent" last="Sapin">Vincent Sapin</name>
<name sortKey="Schmitt, Francois" sort="Schmitt, Francois" uniqKey="Schmitt F" first="François" last="Schmitt">François Schmitt</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000658 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000658 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32540814
   |texte=   SFBC working group "Biochemical markers of COVID-19".
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32540814" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021